Grace Therapeutics, Inc.

Nasdaq:GRCE

Pharmaceutical Preparations·PRINCETON, NJ

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/12/26	→
10-Q/A	Q3 2025	9/30/25	11/17/25	→
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-K	FY 2025	3/31/25	6/23/25	→
10-Q/A	Q4 2024	12/31/24	2/19/25	→
↓

Earnings Releases (8-K)

23 shown

Filed	Period
2/12/26	Q4 FY2026	→
11/13/25	Q3 FY2026	→
8/12/25	Q2 FY2026	→
6/23/25	Q1 FY2026	→
2/13/25	Q4 FY2025	→
11/13/24	Q3 FY2025	→
↓

News (8-K)

57 shown

Filed	Type	Description
1/12/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/23/25	Other	Other Events	→
9/18/25	Other	Other Events	→
9/12/25	Vote	Submission of Matters to a Vote of Security Holders	→
8/27/25	Other	Other Events	→
6/25/25	Other	Other Events	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
3/10/25	S-3	S-3	→
10/8/24	S-8	S-8	→
10/8/24	S-8 POS	S-8 POS	→
10/8/24	S-8 POS	S-8 POS	→
10/8/24	S-8 POS	S-8 POS	→
8/7/24	424B3	424B3	→
↓

Filing History(553 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016618

—

14.0 KB

SCHEDULE 13G/A

Feb 13, 2026

0001104659-26-015316

—

11.2 KB

8-K

Feb 12, 2026

0001140361-26-0049278-K

Feb 12, 2026

337.2 KB

10-Q

Feb 12, 2026

0001140361-26-00492410-Q

Dec 31, 2025

7.6 MB

SCHEDULE 13G/A

Jan 28, 2026

0001493152-26-003982

—

9.4 KB

8-K

Jan 12, 2026

0001140361-26-0009958-K

Jan 10, 2026

329.5 KB

Jan 12, 2026

0001140361-26-000969FORM 4

Jan 8, 2026

5.1 KB

Jan 12, 2026

0001140361-26-000968FORM 4

Jan 8, 2026

5.1 KB

Jan 12, 2026

0001140361-26-000967FORM 4

Jan 8, 2026

5.1 KB

Jan 12, 2026

0001140361-26-000966FORM 4

Jan 8, 2026

5.2 KB

10-Q/A

Nov 17, 2025

0001140361-25-04249110Q/A

Sep 30, 2025

210.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112814

—

13.9 KB

8-K

Nov 13, 2025

0001140361-25-0418078-K

Nov 13, 2025

6.5 MB

10-Q

Nov 13, 2025

0001140361-25-04180410-Q

Sep 30, 2025

5.0 MB

8-K

Oct 23, 2025

0001140361-25-0390208-K

Oct 23, 2025

180.3 KB

8-K

Sep 18, 2025

0001140361-25-0353378-K

Sep 18, 2025

185.8 KB

8-K

Sep 12, 2025

0001140361-25-0348458-K

Sep 12, 2025

165.5 KB

8-K

Aug 27, 2025

0001140361-25-0328478-K

Aug 27, 2025

188.7 KB

SCHEDULE 13G/A

Aug 14, 2025

0001104659-25-078718

—

10.8 KB

8-K

Aug 12, 2025

0001140361-25-0304008-K

Aug 12, 2025

315.0 KB

10-Q

Aug 12, 2025

0001140361-25-03039810-Q

Jun 30, 2025

4.9 MB

DEFA14A

Jul 28, 2025

0001140361-25-027457DEFA14A

—

9.4 MB

DEF 14A

Jul 28, 2025

0001140361-25-027456DEF 14A

Sep 12, 2025

4.8 MB

8-K

Jun 25, 2025

0001140361-25-0235578-K

Jun 25, 2025

186.5 KB

8-K

Jun 23, 2025

0001140361-25-0232618-K

Jun 23, 2025

317.3 KB

25 filings shown

Grace Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(553 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
7/28/25	DEFA14A	DEFA14A	→
7/28/25	DEF 14A	DEF 14A	→
9/6/24	DEFA14A	DEFA14A	→
8/7/24	DEFA14A	DEFA14A	→
8/25/23	DEFA14A	DEFA14A	→
8/25/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/28/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓